1. Home
  2. IMMR vs ENLV Comparison

IMMR vs ENLV Comparison

Compare IMMR & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immersion Corporation

IMMR

Immersion Corporation

HOLD

Current Price

$6.47

Market Cap

216.7M

Sector

Technology

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.84

Market Cap

196.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMMR
ENLV
Founded
1993
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
216.7M
196.2M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
IMMR
ENLV
Price
$6.47
$0.84
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$13.50
$20.00
AVG Volume (30 Days)
575.1K
524.5K
Earning Date
04-13-2026
05-29-2026
Dividend Yield
5.11%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$35,013,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.25
$0.66
52 Week High
$8.15
$2.10

Technical Indicators

Market Signals
Indicator
IMMR
ENLV
Relative Strength Index (RSI) 61.12 41.23
Support Level $6.33 $0.79
Resistance Level $6.98 $1.23
Average True Range (ATR) 0.27 0.06
MACD 0.03 0.00
Stochastic Oscillator 67.16 28.99

Price Performance

Historical Comparison
IMMR
ENLV

About IMMR Immersion Corporation

Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: